Skip to content
Screener

Phathom Pharmaceuticals, Inc. PHAT Q4 2025 Annual earnings

Reported February 26, 2026 · Before market open

Revenue$57.6MBeat by $412.4K
EPS-$0.16Beat by $0.16
Revenue estimate$57.2M
EPS estimate-$0.32

Next report

Date not yet announced

Financials

Q4 2025

Income statement

See full
Revenue$57.6M+94.1%
Gross profit$49.9M+93.2%
Operating income-$5.9M+90.0%
Net income-$21.1M+71.6%
EPS (diluted)-$0.27+73.0%

Balance sheet

See full
Cash & equivalents$130.0M-56.3%
Total debt$211.8M+4.9%
Total equity-$438.2M-72.8%
Total assets$259.1M-31.5%

Cash flow

See full
Operating cash flow-$5.0M+92.1%
CapEx$87.0K+1,640%
Free cash flow-$5.1M+92.0%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$1.18B+113%
Enterprise value$1.26B+174%
P/S6.7×-3.3×

Profitability

See full
Gross margin87.1%+1.5pp
Operating margin-91.4%-41.1pp
Net margin-126.3%-55.8pp
FCF margin-95.4%-42.5pp

Returns & leverage

See full
Current ratio1.7×-2.5×

Segments

By segment

See full
Reportable Segment Aggregation Before Other Operating$57.6M+94.1%

By product

See full
Voquezna Product$57.6M+93.9%

FAQ

When did Phathom Pharmaceuticals, Inc. report Q4 2025 earnings?
Phathom Pharmaceuticals, Inc. (PHAT) reported Q4 2025 earnings on February 26, 2026 before market open.
What were Phathom Pharmaceuticals, Inc.'s Q4 2025 revenue and EPS?
Phathom Pharmaceuticals, Inc. reported revenue of $57.6M and eps of $-0.16 for Q4 2025.
Did Phathom Pharmaceuticals, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $57.2M by $412.4K. EPS beat the consensus estimate of $-0.32 by $0.16.
How did Phathom Pharmaceuticals, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 94.1% from $29.7M a year earlier and eps grew 79.7% from $-0.79.
Where can I find Phathom Pharmaceuticals, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-073377) and the 10-K periodic report (0001193125-26-073379) directly on SEC EDGAR. The filing index links above go to sec.gov.